Correction: Increased levels of plasma soluble SEMA4D in patients with heart failure(PLoS ONE (2013) 8:5 (e64265) DOI: 10.1371/journal.pone.0064265);Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lu, Qiongyu ^a   Dong, Ningzheng ^a   Wang, Qi ^a   Yi, Wenxiu ^a   Wang, Yuxin ^b   Zhang, Shengjie ^a   Gu, Haibo ^a   Zhao, Xin ^a   Tang, Xiaorong ^a   Jin, Boquan ^c   Wu, Qingyu ^a   Brass, Lawrence F ^d   Zhu, Li ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Jilin People's Armed Police Forces Hospital   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTE;

EID: 84878537417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0214894     Document Type: Erratum

References (50)

1. Suzuki K, Kumanogoh A, Kikutani H, (2008) Semaphorins and their receptors in immune cell interactions. Nat Immunol 9: 17-23.
2. Oinuma I, Ito Y, Katoh H, Negishi M, (2010) Semaphorin 4D/Plexin-B1 stimulates PTEN activity through R-Ras GTPase-activating protein activity, inducing growth cone collapse in hippocampal neurons. J Biol Chem 285: 28200-28209.
3. Ito Y, Oinuma I, Katoh H, Kaibuchi K, Negishi M, (2006) Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep 7: 704-709.
4. Oinuma I, Katoh H, Negishi M, (2004) Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons. J Neurosci 24: 11473-11480.
5. Oinuma I, Ishikawa Y, Katoh H, Negishi M, (2004) The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305: 862-865.
6. Ch'ng ES, Kumanogoh A, (2010) Roles of Sema4D and Plexin-B1 in tumor progression. Mol Cancer 9: 251.
7. Binmadi NO, Proia P, Zhou H, Yang YH, Basile JR, (2011) Rho-mediated activation of PI(4)P5K and lipid second messengers is necessary for promotion of angiogenesis by Semaphorin 4D. Angiogenesis 14: 309-319.
8. Zhou H, Binmadi NO, Yang YH, Proia P, Basile JR, (2012) Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. Angiogenesis 15: 391-407.
9. Kato S, Kubota K, Shimamura T, Shinohara Y, Kobayashi N, et al. (2011) Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Sci 102: 2029-2037.
10. Conrotto P, Corso S, Gamberini S, Comoglio PM, Giordano S, (2004) Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23: 5131-5137.
11. Friedel RH, Kerjan G, Rayburn H, Schuller U, Sotelo C, et al. (2007) Plexin-B2 controls the development of cerebellar granule cells. J Neurosci 27: 3921-3932.
12. Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, et al. (2007) Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A 104: 1621-1626.
13. Wannemacher KM, Zhu L, Jiang H, Fong KP, Stalker TJ, et al. (2010) Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 116: 5707-5715.
14. Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, et al. (2001) Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 97: 3498-3504.
15. Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G, (2001) Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 166: 4341-4347.
16. Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, et al. (2005) Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol 17: 439-447.
17. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, et al. (2001) Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 166: 4348-4354.
18. Kumanogoh A, Suzuki K, Ch'ng E, Watanabe C, Marukawa S, et al. (2002) Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol 169: 1175-1181.
19. Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, et al. (2003) Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol 15: 1027-1034.
20. Basile JR, Holmbeck K, Bugge TH, Gutkind JS, (2007) MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 282: 6899-6905.
21. Besliu A, Banica L, Predeteanu D, Vlad V, Ionescu R, et al. (2011) Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients. Autoimmunity 44: 427-436.
22. Okuno T, Nakatsuji Y, Moriya M, Takamatsu H, Nojima S, et al. (2010) Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 184: 1499-1506.
23. Li M, O'Sullivan KM, Jones LK, Lo C, Semple T, et al. (2009) Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. Immunology 128: 114-122.
24. Li M, O'Sullivan KM, Jones LK, Semple T, Kumanogoh A, et al. (2006) CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J Immunol 177: 3406-3412.
25. Smith EP, Shanks K, Lipsky MM, DeTolla LJ, Keegan AD, et al. (2011) Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol 12: 30.
26. Zhu L, Stalker TJ, Fong KP, Jiang H, Tran A, et al. (2009) Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol 29: 1039-1045.
27. Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, et al. (2010) Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Int J Mol Med 26: 39-44.
28. Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, et al. (2011) Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 17: 1473-1480.
29. Dacquin R, Domenget C, Kumanogoh A, Kikutani H, Jurdic P, et al. (2011) Control of Bone Resorption by Semaphorin 4D Is Dependent on Ovarian Function. PLoS One 6: e26627.
30. Jessup M, Brozena S, (2003) Heart failure. N Engl J Med 348: 2007-2018.
31. McMurray JJ, Pfeffer MA, (2005) Heart failure. Lancet 365: 1877-1889.
32. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, et al. (2006) Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev 11: 83-92.
33. Oikonomou E, Tousoulis D, Siasos G, Zaromitidou M, Papavassiliou AG, et al. (2011) The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol 52: 30-40.
34. Subramaniam V, Davis RC, Shantsila E, Lip GY, (2009) Antithrombotic therapy for heart failure in sinus rhythm. Fundam Clin Pharmacol 23: 705-717.
35. von Bibra H, St John Sutton M, (2011) Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling. Curr Heart Fail Rep 8: 242-51.
36. Dong N, Chen S, Yang J, He L, Liu P, et al. (2010) Plasma soluble corin in patients with heart failure. Circ Heart Fail 3: 207-211.
37. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS, (2004) Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 64: 5212-5224.
38. Dong N, Chen S, Wang W, Zhou Y, Wu Q, (2012) Corin in clinical laboratory diagnostics. Clin Chim Acta 413: 378-383.
39. Xu X, Zhu Y, Liu X, Tian Y, Cao Y, et al. (2003) preparation and identification of monoclonal antibodies against CD100 molecule. Chin J cell Mol Immunol 19: 80-82.
40. Dong N, Dong J, Liu P, Xu L, Shi S, et al. (2010) Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clin Chim Acta 411: 1998-2003.
41. Prevost N, Woulfe D, Tanaka T, Brass LF, (2002) Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci U S A 99: 9219-9224.
42. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, et al. (2000) Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13: 621-631.
43. Li N, Boyd K, Dempsey PJ, Vignali DA, (2007) Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development. J Immunol 178: 4214-4221.
44. Esparza J, Vilardell C, Calvo J, Juan M, Vives J, et al. (1999) Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94: 2754-2766.
45. Satoh M, Nakamura M, Satoh H, Saitoh H, Segawa I, et al. (2000) Expression of tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human myocarditis. J Am Coll Cardiol 36: 1288-1294.
46. Satoh H, Nakamura M, Satoh M, Nakajima T, Izumoto H, et al. (2004) Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. Clin Sci (Lond) 106: 301-306.
47. Zavadzkas JA, Mukherjee R, Rivers WT, Patel RK, Meyer EC, et al. (2011) Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling. Am J Physiol Heart Circ Physiol 301: H1656-1666.
48. Zielonka M, Xia J, Friedel RH, Offermanns S, Worzfeld T, (2010) A systematic expression analysis implicates Plexin-B2 and its ligand Sema4C in the regulation of the vascular and endocrine system. Exp Cell Res 316: 2477-2486.
49. Kato S, Kubota K, Shimamura T, Shinohara Y, Kobayashi N, et al. (2011) Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Sci 102: 2029-2037.
50. Carr ME, (2001) Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15: 44-54.